Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Viatris Inc | 45,351 | reported | 06 Mar 2026 | tx 11+107,343−46,524.5 |
| Minerva Neurosciences, Inc. | 41,667 | reported | 01 Jul 2014 | tx 2+540,288 |
| Spark Therapeutics, Inc. | 25,716 | reported | 15 Jul 2016 | tx 30+148,833−170,333 |
| Crinetics Pharmaceuticals, Inc. | 16,823 | reported | 12 Mar 2026 | tx 12+130,400−5,000 |
| Bioverativ Inc. | 0 | reported | 08 Mar 2018 | tx 14+410,572−241,800.04 |
| Sigilon Therapeutics, Inc. | 0 | reported | 11 Aug 2023 | tx 11+1,367,750−75,301 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Mar 2026 | SALE | Crinetics Pharmaceuticals, Inc. | 4,477 | 36.08 USD | |
| 12 Mar 2026 | SALE | Crinetics Pharmaceuticals, Inc. | 523 | 36.77 USD | |
| 06 Mar 2026 | EXERCISE | Viatris Inc | 1,175 | 0.00 USD | |
| 06 Mar 2026 | EXERCISE | Viatris Inc | 23,660 | 0.00 USD | |
| 06 Mar 2026 | GRANT_AWARD | Viatris Inc | 15,890 | 0.00 USD | deriv |
| 06 Mar 2026 | EXERCISE | Viatris Inc | 1,174.49 | 0.00 USD | deriv |
| 06 Mar 2026 | EXERCISE | Viatris Inc | 23,660 | 0.00 USD | deriv |
| 11 Jun 2025 | GRANT_AWARD | Crinetics Pharmaceuticals, Inc. | 6,900 | 0.00 USD | |
| 11 Jun 2025 | GRANT_AWARD | Crinetics Pharmaceuticals, Inc. | 10,350 | 0.00 USD | deriv |
| 06 Mar 2025 | GRANT_AWARD | Viatris Inc | 23,660 | 0.00 USD | deriv |
| 04 Mar 2025 | EXERCISE | Viatris Inc | 424 | 0.00 USD | |
| 04 Mar 2025 | EXERCISE | Viatris Inc | 21,267 | 0.00 USD | |
| 04 Mar 2025 | EXERCISE | Viatris Inc | 21,267 | 0.00 USD | deriv |
| 04 Mar 2025 | EXERCISE | Viatris Inc | 423.01 | 0.00 USD | deriv |
| 07 Jun 2024 | GRANT_AWARD | Crinetics Pharmaceuticals, Inc. | 3,400 | 0.00 USD | |
| 07 Jun 2024 | GRANT_AWARD | Crinetics Pharmaceuticals, Inc. | 12,500 | 0.00 USD | deriv |
| 03 Jun 2024 | GRANT_AWARD | Viatris Inc | 21,267 | 0.00 USD | deriv |
| 11 Aug 2023 | OTHER | Sigilon Therapeutics, Inc. | 12,169 | — | |
| 11 Aug 2023 | OTHER | Sigilon Therapeutics, Inc. | 35,382 | 0.75 USD | deriv |
| 21 Jul 2023 | EXERCISE | Sigilon Therapeutics, Inc. | 5,528 | 19.24 USD | |
| 21 Jul 2023 | EXERCISE | Sigilon Therapeutics, Inc. | 5,528 | 0.00 USD | deriv |
| 16 Jun 2023 | GRANT_AWARD | Crinetics Pharmaceuticals, Inc. | 6,000 | 0.00 USD | |
| 16 Jun 2023 | GRANT_AWARD | Crinetics Pharmaceuticals, Inc. | 17,500 | 0.00 USD | deriv |
| 08 Jun 2023 | PURCHASE | Crinetics Pharmaceuticals, Inc. | 5,000 | 22.06 USD | first after silence |
| 28 Feb 2023 | GRANT_AWARD | Sigilon Therapeutics, Inc. | 460,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 08 Jun 2023.